ResearcherChinese PLA General HospitalActive in the last 2 years
Jing Wang
Matched on OpenAlex author ID A5140762159. Sources: OpenAlex.
Their work
- Papers
- 9 (first author 1, last author 7)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 8
2021: 1 paper · 2022: 1 paper · 2023: 3 papers · 2024: 2 papers · 2025: 1 paper · 2026: 1 paper
Papers 9
- Corrigendum to "Long-Term outcomes of ablative stereotactic body radiation therapy for inoperable, non-metastatic pancreatic cancer" [Radiother. Oncol. 213 (20… Last author DOI 10.1016/j.radonc.2026.111681↗
- Long-Term outcomes of ablative stereotactic body radiation therapy for inoperable, non-metastatic pancreatic cancer. Last author DOI 10.1016/j.radonc.2025.111210↗
- Survival benefits of radiotherapy in locally advanced unresectable and metastatic pancreatic cancer: a single-institution cohort and SEER database analysis. Co-author DOI 10.3389/fonc.2024.1473251↗
- Treatment patterns and survival outcomes in patients with non-metastatic early-onset pancreatic cancer. Last author DOI 10.3748/wjg.v30.i12.1739↗
- Survival Outcomes and Failure Patterns in Patients with Inoperable Non-Metastatic Pancreatic Cancer Treated with Definitive Radiotherapy. Last author DOI 10.3390/cancers15082213↗
- Risk factors, prognostic predictors, and nomograms for pancreatic cancer patients with initially diagnosed synchronous liver metastasis. Last author DOI 10.4251/wjgo.v15.i1.128↗
- Survival benefits and disparities in radiation therapy for elderly patients with pancreatic ductal adenocarcinoma. Last author DOI 10.4251/wjgo.v15.i1.155↗
- Identification of CKS1B as a prognostic indicator and a predictive marker for immunotherapy in pancreatic cancer. First author DOI 10.3389/fimmu.2022.1052768↗
- Identify Prognostic Factors and Establish a Risk Stratification Model to Predict Cancer-Specific Survival for Patients with Pancreatic Cancer Liver Metastasis:… Last author DOI 10.21203/rs.3.rs-855925/v1↗
Closest collaborators
The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Biyang Cao · 8 shared papers, 2021–2026 · strength 2.14
- Paper Corrigendum to "Long-Term outcomes of ablative stereotactic body radiation therapy for inoperable, non-metastatic pancr… DOI 10.1016/j.radonc.2026.111681↗
- Paper Long-Term outcomes of ablative stereotactic body radiation therapy for inoperable, non-metastatic pancreatic cancer. DOI 10.1016/j.radonc.2025.111210↗
- Paper Survival benefits of radiotherapy in locally advanced unresectable and metastatic pancreatic cancer: a single-instituti… DOI 10.3389/fonc.2024.1473251↗
- Letian Zhang · 6 shared papers, 2021–2025 · strength 1.51
- Paper Long-Term outcomes of ablative stereotactic body radiation therapy for inoperable, non-metastatic pancreatic cancer. DOI 10.1016/j.radonc.2025.111210↗
- Paper Survival benefits of radiotherapy in locally advanced unresectable and metastatic pancreatic cancer: a single-instituti… DOI 10.3389/fonc.2024.1473251↗
- Paper Treatment patterns and survival outcomes in patients with non-metastatic early-onset pancreatic cancer. DOI 10.3748/wjg.v30.i12.1739↗
- Lin Yang · 1 shared paper, 2024 · strength 0.28
- Qianqian Wang · 1 shared paper, 2023 · strength 0.19
- Zhaoda Deng · 1 shared paper, 2022 · strength 0.15
- Lincheng Li · 1 shared paper, 2022 · strength 0.15
- Wenbo Zou · 1 shared paper, 2022 · strength 0.15
- Rong Liu · 1 shared paper, 2022 · strength 0.15
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.